Literature DB >> 22784457

The roles of genetic and environmental factors on risk of cervical cancer: a review of classical twin studies.

Elya E Moore1, John D Wark, John L Hopper, Bircan Erbas, Suzanne M Garland.   

Abstract

Cervical cancer is the third most common cancer in women worldwide. Persistent infection with an oncogenic human papillomavirus (HPV) is necessary, but not sufficient, for its development. Over many years, only a small proportion of women with chronic HPV infection progress to develop disease. The role of host genes and environmental factors in the pathogenesis of, or predisposition to, cervical cancer is still unclear. We conducted a systematic review of published literature in MEDLINE-PubMed to identify studies of cervical cancer susceptibility that used a twin study design. We used standard MeSH terms (controlled vocabulary) as well as specific free-text terms and combinations of terms related to cervical cancer, with no restriction on publication date. We performed a full text review to ensure the identified articles met our inclusion criteria and, if so, extracted information on demographics, sample size, study definitions, and key statistical findings. Of the 285 articles identified, three utilized a classical twin design and reported results specific to cervical cancer. The studies were based on cancer registry data from Scandinavia, with sample sizes ranging from 312 to 710 twin pairs. The findings from one study were consistent with a genetic mechanism for the causation of carcinoma in situ. Future research studies using the strength of the classic twin design, together with incorporation of HPV DNA status, are indicated to determine whether there is a potential role for genetic factors in the development of cervical cancer or high-grade cervical dysplasia from chronic oncogenic HPV infection.

Entities:  

Mesh:

Year:  2012        PMID: 22784457     DOI: 10.1375/twin.15.1.79

Source DB:  PubMed          Journal:  Twin Res Hum Genet        ISSN: 1832-4274            Impact factor:   1.587


  18 in total

1.  Neuropathologic assessment of dementia markers in identical and fraternal twins.

Authors:  Diego Iacono; Inga Volkman; Inger Nennesmo; Nancy L Pedersen; Laura Fratiglioni; Boo Johansson; David Karlsson; Bengt Winblad; Margaret Gatz
Journal:  Brain Pathol       Date:  2014-03-07       Impact factor: 6.508

Review 2.  Significant association between CYP1A1 T3801C polymorphism and cervical neoplasia risk: a systematic review and meta-analysis.

Authors:  Liangbin Xia; Jing Gao; Yan Liu; Ke Wu
Journal:  Tumour Biol       Date:  2012-10-04

3.  Antiproliferative and apoptotic potential of Glycyrrhizin against HPV16+ Caski cervical cancer cells: A plausible association with downreguation of HPV E6 and E7 oncogenes and Notch signaling pathway.

Authors:  Afza Ahmad; Rohit Kumar Tiwari; Prakriti Mishra; Ali G Alkhathami; Tahani M Almeleebia; Mohammad Y Alshahrani; Irfan Ahmad; Rawan Amer Asiri; Noura M Alabdullah; Mohamed Hussien; Mohd Saeed; Irfan Ahmad Ansari
Journal:  Saudi J Biol Sci       Date:  2022-01-31       Impact factor: 4.052

4.  Association between the p73 gene G4C14-to-A4T14 single nucleotide polymorphism and risk of cervical cancer by high resolution melting and PCR with confronting two-pair primers in a Chinese population.

Authors:  Haiyan Guo; Shaodi Yang; Lijian Xu; Ding Li; Jianxin Tang; Shuangshaung Wang; Benjie Wei; Zhengchun Liu
Journal:  Oncol Lett       Date:  2016-06-01       Impact factor: 2.967

5.  RPS19 and TYMS SNPs and Prevalent High Risk Human Papilloma Virus Infection in Nigerian Women.

Authors:  Ayo Famooto; Maryam Almujtaba; Eileen Dareng; Sally Akarolo-Anthony; Celestine Ogbonna; Richard Offiong; Olayinka Olaniyan; Cosette M Wheeler; Ayo Doumatey; Charles N Rotimi; Adebowale Adeyemo; Clement A Adebamowo
Journal:  PLoS One       Date:  2013-06-27       Impact factor: 3.240

6.  Awareness and knowledge regarding of cervical cancer, Pap smear screening and human papillomavirus infection in Gabonese women.

Authors:  Samira Zoa Assoumou; Barthelemy Mabika Mabika; Angelique Ndjoyi Mbiguino; Mustapha Mouallif; Abdelkim Khattabi; My Mustapha Ennaji
Journal:  BMC Womens Health       Date:  2015-04-19       Impact factor: 2.809

Review 7.  Human papillomavirus genotypes in cervical cancer and vaccination challenges in Zimbabwe.

Authors:  Nyasha Chin'ombe; Natasha L Sebata; Vurayai Ruhanya; Hilda T Matarira
Journal:  Infect Agent Cancer       Date:  2014-05-13       Impact factor: 2.965

8.  Cucurbitacin D exhibits potent anti-cancer activity in cervical cancer.

Authors:  Mohammed Sikander; Bilal Bin Hafeez; Shabnam Malik; Abdulrhman Alsayari; Fathi T Halaweish; Murali M Yallapu; Subhash C Chauhan; Meena Jaggi
Journal:  Sci Rep       Date:  2016-11-08       Impact factor: 4.379

9.  Naturopathic management of females with cervical atypia: a delphi process to explore current practice.

Authors:  Cynthia Ann Leaver; Claiborne Miller-Davis; Gwenyth R Wallen
Journal:  Integr Med Insights       Date:  2013-01-31

10.  Curcumin Nanoformulation for Cervical Cancer Treatment.

Authors:  Mohd S Zaman; Neeraj Chauhan; Murali M Yallapu; Rishi K Gara; Diane M Maher; Sonam Kumari; Mohammed Sikander; Sheema Khan; Nadeem Zafar; Meena Jaggi; Subhash C Chauhan
Journal:  Sci Rep       Date:  2016-02-03       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.